International Collaborations
International collaborations are essential to advancing scientific discovery and fostering innovation, while also requiring careful adherence to federal regulations, sponsor requirements, and institutional policies. Activities involving foreign institutions or researchers may introduce specific compliance considerations, including disclosure, prior approvals, and research security risks. Please review the sections below for additional guidance and resources related to international collaborations, and please contact the Export Control team early to ensure all applicable disclosure, approval, and risk management requirements are appropriately addressed.
NIH funding recipients are required to disclose and obtain prior NIH approval for any collaboration that qualifies as a ‘foreign component’. NIH emphasizes strict oversight and enforcement, particularly through review of publications cited in progress reports (RPPRs), and the evaluation of foreign-co-authorship and affiliations.
Visit the NIH Foreign Components page
The CHIPS and Science Act of 2022 prohibits federal employees, contractors, and awardees from participating in Malign Foreign Talent Recruitment Programs (MFTRPs). While most talent recruitment programs are upstanding and promote a healthy exchange of culture and knowledge, some are part of a broader whole-of-government strategy to surreptitiously obtain U.S. technologies. These programs are considered malign and are generally one-sided, as well as contradictory to the Medical Center’s values. Review the Malign Foreign Talen Recruitment Program page for information on identifying MFTRPs. Review the Malign Foreign Talent Recruitment Program page for information on identifying MFTRPs.
